Eflapegrastim | m-entrepreneurship.com

Product Name :
Eflapegrastim

Search keywords :
Eflapegrastim

drugId :
null

Target Vo:
Colony stimulating factor 3 receptor

Target Vo Short Name :
CSF3R

Moa_Name:
Colony stimulating factor 3 receptor agonists

First Approval Country :
South Korea

First Approval Date Filter:
2021

Origin Company_Name :
Hanmi Pharmaceutical Co Ltd

Active Company_Name :
Hanmi Pharmaceutical Co Ltd

Active Indication_Name:
Febrile Neutropenia

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
FOXP3 Mouse (YP6049) mAb Cancer
Ezabenlimab Technical Information
Mucin 2 Antibody: Mucin 2 Antibody is an unconjugated, rabbit-derived, anti-Mucin 2 monoclonal antibody. Mucin 2 Antibody can be used for: WB, IHC-P, ICC/IF, IP, FC expriments in human, rat background without labeling.

Author: Betaine hydrochloride

Related Posts